C92.02: Acute myeloblastic leukemia, in relapse
C92.02 is a billable, specific ICD-10-CM code for acute myeloblastic leukemia, in relapse. It is valid for submission on a claim.
Check C92.02 with the rest of the claim: free scrubberExcludes1 inherited from the categories above C92.02
A category’s note binds every code beneath it.
Written on C92.0: Acute myeloblastic leukemia
Other codes that can never be billed with C92.02
Their own Excludes1 notes name this code, so the conflict is not listed above.
- D72.825Bandemia
Risk adjustment
C92.02 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 17 Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic4.209 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C92.02 is named in 56 Medicare coverage policies: 54 listing it as supporting medical necessity, and 2 listing it as NOT covered. Which one applies depends on your Medicare contractor.
- A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)not covered
- A60435Billing and Coding: Erythropoiesis Stimulating Agents (ESA)not covered
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
Code history
Unchanged in every release from FY2024 to FY2027.